| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.1 | 0.4 |